The DNA co-vaccination using Sm antigen and IL-10 as prophylactic experimental therapy ameliorates nephritis in a model of lupus induced by pristane

PLoS One. 2021 Oct 27;16(10):e0259114. doi: 10.1371/journal.pone.0259114. eCollection 2021.

Abstract

Introduction: Systemic lupus erythematosus (SLE) is an autoimmune disease characterized by the production of autoantibodies such as anti-Sm. Studies in patients with SLE and murine models of lupus reveal that the most critical anti-Sm autoantibodies are predominantly direct against D1(83-119), D2, and B´/B epitopes.

Objectives: The present study aimed to analyze the induction of antigen-specific tolerance after prophylactic immunization with a DNA vaccine encoding the epitopes: D183-119, D2, B´/B, and B´/BCOOH in co-vaccination with IFN-γ or IL-10 in a murine model of lupus induced by pristane.

Material and methods: To obtain endotoxin-free DNA vaccines, direct cloning techniques using pcDNA were performed: D183-119, D2, B´/B, B´/BCOOH, IFN-γ, or IL-10. Lupus was induced by 0.5 mL of pristane via intraperitoneal in BALB/c female mice. Immunoprecipitation with K562 cells was metabolically labeled with 35S and ELISA to detect serum antibodies or mice IgG1, IgG2a isotypes. ELISA determined IL-10 and IFN-γ from splenocytes supernatants. Proteinuria was assessed monthly, and lupus nephritis was evaluated by immunofluorescence, and electron microscopy.

Results: The prophylactic co-vaccination with D2/IL-10 reduced the expression of kidney damage observed by electron microscopy, direct immunofluorescence, and H & E, along with reduced level of anti-nRNP/Sm antibodies (P = 0.048).

Conclusion: The prophylactic co-vaccination of IL-10 with D2 in pristane-induced lupus ameliorates the renal damage maybe by acting as prophylactic DNA tolerizing therapy.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Autoantibodies / immunology
  • Autoantigens / immunology
  • Female
  • Interleukin-10* / administration & dosage
  • Interleukin-10* / pharmacology
  • Lupus Erythematosus, Systemic / prevention & control*
  • Mice
  • Mice, Inbred BALB C
  • Therapies, Investigational
  • Vaccination
  • Vaccines, DNA* / administration & dosage
  • Vaccines, DNA* / pharmacology

Substances

  • Autoantibodies
  • Autoantigens
  • Vaccines, DNA
  • Interleukin-10

Grants and funding

MVM Grant 51353 supported by SEP-CONACyT 51353 grant from Consejo Nacional de Ciencia y Tecnología (CONACyT). URL:http://www.conacyt.gob.mx The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.